Form 4: Forte Biosciences Director Reports Stock Transaction
Insider Transaction (Form 4)
Stephen K Doberstein, a Director of Forte Biosciences, Inc., reported multiple transactions in common stock on August 27, 2026.
Summary
- Disposition to the issuer: disposed of 2,000 Stock Option (right to buy) on August 27, 2026 (Direct).
- Disposition to the issuer: disposed of 1,000 Stock Option (right to buy) on August 27, 2026 (Direct).
- Disposition to the issuer: disposed of 1,000 Stock Option (right to buy) on August 27, 2026 (Direct).
- Disposition to the issuer: disposed of 2,000 Stock Option (right to buy) on August 27, 2026 (Direct).
- Disposition to the issuer: disposed of 31,000 Stock Option (right to buy) on August 27, 2026 (Direct).
- Disposition to the issuer: disposed of 18,353 Restricted Stock Units on August 27, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Stephen K Doberstein — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-27 | Disposition to the issuer | Stock Option (right to buy) | 2,000 | — | — | 0 |
| 2026-08-27 | Disposition to the issuer | Stock Option (right to buy) | 1,000 | — | — | 0 |
| 2026-08-27 | Disposition to the issuer | Stock Option (right to buy) | 1,000 | — | — | 0 |
| 2026-08-27 | Disposition to the issuer | Stock Option (right to buy) | 2,000 | — | — | 0 |
| 2026-08-27 | Disposition to the issuer | Stock Option (right to buy) | 31,000 | — | — | 0 |
| 2026-08-27 | Disposition to the issuer | Restricted Stock Units | 18,353 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-27 | Disposition to the issuer (2,000 shares) |
| 2026-08-27 | Disposition to the issuer (1,000 shares) |
| 2026-08-27 | Disposition to the issuer (1,000 shares) |
| 2026-08-27 | Disposition to the issuer (2,000 shares) |
| 2026-08-27 | Disposition to the issuer (31,000 shares) |
| 2026-08-27 | Disposition to the issuer (18,353 shares) |
Keywords
insider transaction, Form 4, FBRX, Forte Biosciences, Inc., neutral, Stephen K Doberstein
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.